CAD 0.05
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 757.75 Million USD | -3.82% |
2022 | 787.82 Million USD | -4.59% |
2021 | 825.68 Million USD | 75.41% |
2020 | 470.71 Million USD | 247.79% |
2019 | 135.34 Million USD | 13.39% |
2018 | 119.35 Million CAD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 753.73 Million USD | -2.02% |
2024 Q1 | 769.92 Million USD | 2.02% |
2023 Q2 | 797.19 Million USD | 0.69% |
2023 Q4 | 757.75 Million USD | -5.0% |
2023 FY | 757.75 Million USD | -3.82% |
2023 Q1 | 791.69 Million USD | 0.49% |
2023 Q3 | 797.6 Million USD | 0.05% |
2022 Q4 | 787.82 Million USD | -9.52% |
2022 Q3 | 870.7 Million USD | -2.44% |
2022 FY | 787.82 Million USD | -4.59% |
2022 Q2 | 892.49 Million USD | -6.32% |
2022 Q1 | 952.74 Million USD | 15.39% |
2021 Q1 | 488.45 Million USD | 3.77% |
2021 FY | 825.68 Million USD | 75.41% |
2021 Q4 | 825.68 Million USD | -3.84% |
2021 Q3 | 858.67 Million USD | -1.44% |
2021 Q2 | 871.22 Million USD | 78.36% |
2020 Q1 | 153.28 Million USD | 13.25% |
2020 FY | 470.71 Million USD | 247.79% |
2020 Q4 | 470.71 Million USD | 19.28% |
2020 Q3 | 394.61 Million USD | 117.23% |
2020 Q2 | 181.66 Million USD | 18.51% |
2019 Q1 | 121.64 Million CAD | 0.0% |
2019 Q3 | 71.38 Million USD | -1.9% |
2019 Q2 | 72.76 Million USD | -40.18% |
2019 FY | 135.34 Million USD | 13.39% |
2019 Q4 | 135.34 Million USD | 89.61% |
2018 Q3 | 36.06 Million CAD | 0.0% |
2018 FY | 119.35 Million CAD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Filament Health Corp. | 3.08 Million CAD | -24466.353% |